Request for Information (RFI): Challenges and Opportunities in Health and Science Communication Research (PDF) May 25, 2022 Collene Lawhorn, PhD Program Officer, National Institute of Mental Health (NIMH) Nadra Tyus, […]
Letters + Comments
NHC Comments to the FTC on PBM Business Practices and the Impact on Independent Pharmacies and Consumers
NHC Comments to the FTC on PBM Business Practices and the Impact on Independent Pharmacies and Consumers (PDF) May 25, 2022 Federal Trade Commission 600 Pennsylvania Avenue, NW Washington, DC […]
NHC MDUFA V Public Meeting Comments
Statement by Jennifer Dexter Assistant Vice President, Policy National Health Council MDUFA V Public Meeting April 19, 2022 MDUFA V Public Meeting (PDF) Thank you for the opportunity to be […]
National Health Council’s (NHC’s) responses to the CMS Request for Information on Access to Care and Coverage for People Enrolled in Medicaid and CHIP
NHC’s Responses to the CMS Request for Information on Access to Care and Coverage for People Enrolled in Medicaid and CHIP (PDF) The following are the National Health Council’s (NHC’s) […]
NHC Comment Letter on the Potential Expiration of the Public Health Emergency
PHE Priorities Comment Letter (PDF) March 18, 2022 The Honorable Nancy Pelosi U.S. House of Representatives Washington, DC 20515 The Honorable Kevin McCarthy U.S. House of Representatives Washington, DC 20515 […]
Examining Charitable Giving and Trends in the Nonprofit Sector
Examining Charitable Giving and Trends in the Nonprofit Sector March 17, 2022, 10:00 a.m. United States Senate Committee on FinanceRandall L. RuttaChief Executive Officer 1730 M St NW, Suite 500Washington, […]
Statement for the Record: FDA User Fee Reauthorization: Ensuring Safe and Effective Drugs and Biologics
Statement for the Record: FDA User Fee Reauthorization: Ensuring Safe and Effective Drugs and Biologics February 3, 2022, 10:30 a.m. United States House Committee on Energy and CommerceRandall L. RuttaChief […]
NHC Comments on HHS Notice of Benefit and Payment Parameters for 2023
NHC 2023 NBPP Comments on Letterhead January 27, 2022 Chiquita Brooks-LaSure Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services 7500 Security Blvd Baltimore, MD 212441 […]
Letter of Support for Dr. Robert Califf FDA Commissioner Nominee
Califf Nomination Letter Final (PDF) December 13, 2021 The Honorable Patty Murray Chair Committee on Health, Education, Labor, and Pensions United States Senate 154 Russell Office Building Washington, DC 20510 […]
NHC Comments on FDA-2020-D-2316 for Benefit-Risk Assessment for New Drug and Biological Products; Draft Guidance for Industry
Food and Drug Administration Dockets Management Staff (HFA-305) 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 RE: FDA-2020-D-2316 for “Benefit-Risk Assessment for New Drug and Biological Products; Draft Guidance for […]